Comments: NJ A973 | 2020-2021 | Regular Session

Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone under certain conditions.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2020-01-14 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee [A973 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2020 New Jersey A973 at this time.

Social Comments on NJ A973

feedback